Global expansion BÜHLMANN operates with local teams across multiple European regions plus the USA and Brazil, plus worldwide distributors, presenting a broad addressable market for DIA tests, calprotectin assays, and therapeutic drug monitoring solutions.

Calprotectin leadership The company is a leading provider of calprotectin tests with a broad portfolio including automated turbidimetric and ELISA platforms, offering opportunities to upsell integrated workflows and higher throughput solutions to clinical labs and hospitals.

Strategic partnership Recent acquisition by KLAR Partners signals growth support and potential co-development, enabling accelerated market penetration, expanded product development, and larger sales campaigns targeting new labs and MCOs.

Regulatory and quality Certified EN ISO 13485:2016 and MDSAP with GMP manufacturing, appealing to risk-averse customers seeking compliant, high-quality IVD solutions; leverage for competitive differentiation and enterprise procurement deals.

Product diversification Diverse portfolio includes Flow CAST Basophil Activation Testing, GanglioCombi ganglioside antibody ELISAs, and therapeutic drug monitoring — enabling cross-sell opportunities to labs serving autoimmune, neurology, and inflammatory disease markets.